“Inhibition of IL-12/IL-23 signaling reduces Alzheimer’s disease–like pathology and cognitive decline,” by Johannes vom Berg, Stefan Prokop, Kelly R. Miller, Juliane Obst, Roland E. Kälin, Ileana Lopategui-Cabezas, Anja Wegner, Florian Mair, Carola G. Schipke, Oliver Peters, York Winter, Burkhard Becher, and Frank L. Heppner (Vol. 18, No. 12, December 2012, p. 1812-1819).
December 6, 2012
No Comments
No comments yet.
RSS feed for comments on this post.
Sorry, the comment form is closed at this time.
